Sung Who Park
Pusan National University
OphthalmologyOptometrySurgeryRetrospective cohort studyChoroidRetinaMacular holeVisual acuityOptical coherence tomographyFluorescein angiographyMacular edemaRetinal detachmentRetinalRanibizumabVitrectomyEpiretinal membraneSubretinal fluidScleral bucklingInternal limiting membraneMedicine
116Publications
11H-index
403Citations
Publications 115
Newest
Source
PURPOSE To describe the development of multiple retinal hemorrhages after uncomplicated macular hole (MH) surgery, and to determine the associated factors. METHODS The medical records of 163 patients (167 eyes) diagnosed with idiopathic MHs and who underwent surgery at Pusan National University Hospital between March 2016 and July 2018 were retrospectively reviewed. The development of retinal hemorrhages was evaluated using ultra-widefield fundus photographs. Multiple retinal hemorrhages were de...
Source
Source
Source
#1Sun Ho Park (PNU: Pusan National University)H-Index: 1
#2Keun Heung Park (PNU: Pusan National University)H-Index: 6
Last. Ji Eun Lee (PNU: Pusan National University)H-Index: 19
view all 8 authors...
Purpose To investigate the correlation between postoperative metamorphopsia and macular deformation after macular hole (MH) surgery. Methods This study included 28 eyes of 28 patients who underwent vitrectomy and internal limiting membrane (ILM) removal for idiopathic MH. The retinal vasculatures were compared between preoperative and postoperative photographs, and postoperative deformation of the macula was assessed as deformation of the square grid. The displacement of each node was measured, ...
1 CitationsSource
Source
Source
#1Yu Cheol Kim (KMU: Keimyung University)H-Index: 2
#1Yu Cheol KimH-Index: 7
Last. Ji Eun Lee (PNU: Pusan National University)H-Index: 19
view all 9 authors...
This study was performed to investigate the efficacy of the treat-and-extend regimen using aflibercept for treating diabetic macular oedema (DME). This prospective, multicentre, interventional, single-arm, 104-week clinical trial included 48 patients with DME visual impairment. The patients' eyes received five consecutive intravitreal injections (2 mg aflibercept) every four weeks with two-week adjustments based on central subfield macular thickness (CSMT) changes. Injections were deferred when ...
Source
Source
Source